Huang YH - Search Results

1

Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases.

Cheng PN, Chen WJ, Hou CJ, Lin CL, Chang ML, Wang CC, Chang WT, Wang CY, Lin CY, Hung CL, Peng CY, Yu ML, Chao TH, Huang JF, Huang YH, Chen CY, Chiang CE, Lin HC, Li YH, Lin TH, Kao JH, Wang TD, Liu PY, Wu YW, Liu CJ. Cheng PN, et al. Among authors: huang yh, huang jf. Clin Mol Hepatol. 2024 Jan;30(1):16-36. doi: 10.3350/cmh.2023.0315. Epub 2023 Oct 4. Clin Mol Hepatol. 2024. PMID: 37793641 Free PMC article. Review.

2

Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.

Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Huang YH, Lee PC, Chang FY, Lee SD. Huo TI, et al. Among authors: huang yh. Liver Transpl. 2004 Dec;10(12):1507-13. doi: 10.1002/lt.20310. Liver Transpl. 2004. PMID: 15558587 Free article.

3

Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy.

Huo TI, Huang YH, Lin HC, Wu JC, Chiang JH, Lee PC, Chang FY, Lee SD. Huo TI, et al. Among authors: huang yh. Am J Gastroenterol. 2006 May;101(5):975-82. doi: 10.1111/j.1572-0241.2006.00462.x. Am J Gastroenterol. 2006. PMID: 16573785

4

The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.

Huo TI, Lin HC, Huang YH, Wu JC, Chiang JH, Lee PC, Lee SD. Huo TI, et al. Among authors: huang yh. Cancer. 2006 Jul 1;107(1):141-8. doi: 10.1002/cncr.21972. Cancer. 2006. PMID: 16708358 Free article.

5

The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy.

Huo TI, Lee PC, Huang YH, Wu JC, Lin HC, Chiang JH, Lee SD. Huo TI, et al. Among authors: huang yh. J Clin Gastroenterol. 2006 Jul;40(6):543-50. doi: 10.1097/00004836-200607000-00014. J Clin Gastroenterol. 2006. PMID: 16825938

6

Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury.

Huang YS, Su WJ, Huang YH, Chen CY, Chang FY, Lin HC, Lee SD. Huang YS, et al. Among authors: huang yh. J Hepatol. 2007 Jul;47(1):128-34. doi: 10.1016/j.jhep.2007.02.009. Epub 2007 Mar 6. J Hepatol. 2007. PMID: 17400324

7

Successful radiofrequency ablation therapy for hepatocellular carcinoma in a male patient with early stage primary biliary cirrhosis and positive serum hepatitis B core antibody.

Su CW, Wu JC, Chiou YY, Tsay SH, Huo TI, Huang YH, Hung HH, Lin HC, Lee SD. Su CW, et al. Among authors: huang yh. J Chin Med Assoc. 2008 Jan;71(1):40-4. doi: 10.1016/S1726-4901(08)70071-6. J Chin Med Assoc. 2008. PMID: 18218559 Free article.

8

Cholestatic jaundice as the predominant presentation in a patient with autoimmune hepatitis.

Tang CP, Shiau YT, Huang YH, Tsay SH, Huo TI, Wu JC, Lin HC, Lee SD. Tang CP, et al. Among authors: huang yh. J Chin Med Assoc. 2008 Jan;71(1):45-8. doi: 10.1016/S1726-4901(08)70072-8. J Chin Med Assoc. 2008. PMID: 18218560 Free article.

9

Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy.

Huo TI, Huang YH, Su CW, Lin HC, Chiang JH, Chiou YY, Huo SC, Lee PC, Lee SD. Huo TI, et al. Among authors: huang yh. Clin Transplant. 2008 Jul-Aug;22(4):469-75. doi: 10.1111/j.1399-0012.2008.00811.x. Epub 2008 Mar 3. Clin Transplant. 2008. PMID: 18318736

10

Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years.

Su CW, Hung HH, Huo TI, Huang YH, Li CP, Lin HC, Lee PC, Lee SD, Wu JC. Su CW, et al. Among authors: huang yh. Liver Int. 2008 Nov;28(9):1305-13. doi: 10.1111/j.1478-3231.2008.01715.x. Epub 2008 Mar 13. Liver Int. 2008. PMID: 18346129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,427 results

Search Page